INFLUENZA, HUMAN
Clinical trials for INFLUENZA, HUMAN explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA, HUMAN trials appear
Sign up with your email to follow new studies for INFLUENZA, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA flu shots enter human testing – could they beat the seasonal bug?
⭐️ VACCINE ⭐️ OngoingThis study tests new mRNA-based flu vaccines in about 971 healthy adults aged 18 and older. The goal is to see if these vaccines are safe and trigger a strong immune response against seasonal flu. Participants receive the vaccine and are monitored for side effects and antibody le…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 06:46 UTC
-
New mRNA flu shots enter human testing
⭐️ VACCINE ⭐️ OngoingThis study tests new mRNA-based seasonal flu vaccines in 776 healthy adults aged 18 and older. The goal is to see how well the vaccines trigger an immune response and whether they are safe. Participants will be monitored for side effects like pain, fever, and fatigue. The vaccine…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:01 UTC
-
Nasal vs. needle: which flu vaccine works better?
⭐️ VACCINE ⭐️ OngoingThis study compares two types of flu vaccines: a nasal spray and a standard shot. Researchers want to see how well each vaccine triggers immune responses in the nose and blood. The goal is to find ways to make flu vaccines more effective. Healthy adults aged 18 to 49 can join.
Matched conditions: INFLUENZA, HUMAN
Phase: EARLY_PHASE1 • Sponsor: Copenhagen Respiratory Research • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:00 UTC
-
New flu shot aims to better protect seniors
Prevention OngoingThis study tests whether a specially formulated flu vaccine (Fluad) works better than the standard flu shot for people aged 65 and older. About 35,800 volunteers will receive either the enhanced or standard vaccine, and researchers will track who gets the flu over the following m…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE3 • Sponsor: Seqirus • Aim: Prevention
Last updated May 17, 2026 06:48 UTC
-
A letter could save your life: pharmacists nudge 20,000 albertans to vaccinate
Prevention OngoingThis study tests whether sending a friendly letter from a pharmacist can motivate more adults to get their flu or travel vaccines. About 20,000 people in Alberta who visited a Mint Pharmacy will receive one of two types of letters: one highlighting flu and heart health benefits, …
Matched conditions: INFLUENZA, HUMAN
Phase: NA • Sponsor: University of Calgary • Aim: Prevention
Last updated May 13, 2026 16:04 UTC